doi: 10.7164/antibiotics.31.667.
Tallysomycin, a new antitumor antibiotic complex related to bleomycin. III. Antitumor activity of tallysomycins A and B
- PMID: 80402
- DOI: 10.7164/antibiotics.31.667
Item in Clipboard
Tallysomycin, a new antitumor antibiotic complex related to bleomycin. III. Antitumor activity of tallysomycins A and B
J Antibiot (Tokyo).
1978 Jul.
Free article
Abstract
The antitumor activity of tallysomycins A and B was determined in five experimental tumor systems in mice. Tallysomycins A and B were highly active against B16 melanoma, sarcoma 180 ascites tumor and Lewis lung carcinoma, and moderately active against P388 leukemia but were without effect on lymphoid leukemia L1210. The antitumor activity of tallysomycin A was 2 to 3 times that of tallysomycin B and 3 to 17 times that of bleomycin. Tallysomycin A was about 1.5 and 4 times more toxic for mice than tallysomycin B and bleomycin, respectively, in terms of subacute LD50 values.
Similar articles
-
Tallysomycin, a new antitumor antibiotic complex related to bleomycin. V. Production, characterization and antitumor activity of tallysomycin S10b, a new biosynthetic tallysomycin derivative.J Antibiot (Tokyo). 1981 Jun;34(6):665-74. doi: 10.7164/antibiotics.34.665. J Antibiot (Tokyo). 1981. PMID: 6168631
-
Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.Cancer Res. 1975 Apr;35(4):939-45. Cancer Res. 1975. PMID: 1116151
-
Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics.Cancer Chemother Pharmacol. 1982;8(2):157-62. doi: 10.1007/BF00255476. Cancer Chemother Pharmacol. 1982. PMID: 7105379
-
The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review.Invest New Drugs. 1985;3(1):3-21. doi: 10.1007/BF00176819. Invest New Drugs. 1985. PMID: 3886588 Review.
-
The clinical impact of screening and other experimental tumor studies.Cancer Treat Rev. 1975 Mar;2(1):1-31. doi: 10.1016/s0305-7372(75)80013-2. Cancer Treat Rev. 1975. PMID: 1102083 Review. No abstract available.
Cited by
-
Tallysomycin S10b: experimental antitumor activity and toxicity.Cancer Chemother Pharmacol. 1984;13(3):164-70. doi: 10.1007/BF00269022. Cancer Chemother Pharmacol. 1984. PMID: 6207948
-
Phase I trial of tallysomycin S10b, a bleomycin analogue.Invest New Drugs. 1990 May;8(2):171-80. doi: 10.1007/BF00177253. Invest New Drugs. 1990. PMID: 1696567
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
